Prostaglandin F2alpha and E1 in plasma and amniotic fluid during human pregnancy and labor. 1977

K Kinoshita, and K Satoh, and S Sakamoto

In order to elucidate the significance of PGs in human labor, PGE1 and F2alpha in biological fluid during human pregnancy and labor were measured by RIA newly developed. Analytical studies demonstrated that the levels of PGF2alpha in maternal plasma were 3.7 +/- 2.5 ng/ml a few days before parturition, 2.0 +/- 0.9 ng/ml in the first stage of labor and 1.9 +/- 1.4 ng/ml at delivery. Thus the concentrations of PGF2alpha in maternal plasma showed no significant changes around parturition. On the otherhand, the level of PGF2alpha in amniotic fluid represented a significant increase up to 44.27 +/- 32.81 ng/ml at delivery from 1.45 +/- 0.76 ng/ml before labor at 38-40 weeks of pregnancy (p less than 0.05), although it was uncertain whether this elevation was the cause or effect of uterine contraction. The concentration of PGE1 ranged from 2 to 14 ng/ml around parturition. This indicates that there was little remarkable difference between the levels of PGE1 in plasma and amniotic fluid during the last month of pregnancy and labor. Possible involvement of prostaglandins (PGs) in human labor has been discussed.

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D007743 Labor, Obstetric The repetitive uterine contraction during childbirth which is associated with the progressive dilation of the uterine cervix (CERVIX UTERI). Successful labor results in the expulsion of the FETUS and PLACENTA. Obstetric labor can be spontaneous or induced (LABOR, INDUCED). Obstetric Labor
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011263 Pregnancy Trimester, Third The last third of a human PREGNANCY, from the beginning of the 29th through the 42nd completed week (197 to 294 days) of gestation. Pregnancy, Third Trimester,Trimester, Third,Last Trimester,Last Trimesters,Pregnancies, Third Trimester,Pregnancy Trimesters, Third,Third Pregnancy Trimester,Third Pregnancy Trimesters,Third Trimester,Third Trimester Pregnancies,Third Trimester Pregnancy,Third Trimesters,Trimester, Last,Trimesters, Last,Trimesters, Third
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D011460 Prostaglandins F (9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics. PGF
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Kinoshita, and K Satoh, and S Sakamoto
July 1979, Archives of gynecology,
K Kinoshita, and K Satoh, and S Sakamoto
January 1974, The Journal of obstetrics and gynaecology of the British Commonwealth,
K Kinoshita, and K Satoh, and S Sakamoto
March 1978, Obstetrics and gynecology,
K Kinoshita, and K Satoh, and S Sakamoto
June 1979, American journal of obstetrics and gynecology,
K Kinoshita, and K Satoh, and S Sakamoto
September 1974, American journal of obstetrics and gynecology,
K Kinoshita, and K Satoh, and S Sakamoto
April 1974, The Journal of obstetrics and gynaecology of the British Commonwealth,
K Kinoshita, and K Satoh, and S Sakamoto
October 1976, Obstetrics and gynecology,
K Kinoshita, and K Satoh, and S Sakamoto
June 1972, Prostaglandins,
Copied contents to your clipboard!